Trial · NCT03716115
Therapeutic Approaches to Malnutrition Enteropathy
NCT03716115, Phase 2, Completed, Queen Mary University of London
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Therapeutic Approaches to Malnutrition Enteropathy. Trials, record NCT03716115. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03716115
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Therapeutic Approaches to Malnutrition Enteropathy
- NCT number
- NCT03716115
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 125 participants, actual
- Lead sponsor
- Queen Mary University of London
- Conditions
- Severe Acute Malnutrition
- Interventions
- Colostrum high protein powder (Neovite), N-Acetyl Glucosamine (GInNAC), Teduglutide, Budesonide
- First posted
- 2018-10-23
- Last updated
- 2021-09-27
Source ClinicalTrials.gov
Registered outcomes21
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Composite measure of concentration of three faecal inflammatory markers | 14-18 days | Composite measure of concentration of three faecal inflammatory markers (myeloperoxidase, neopterin, alpha1-antitrypsin) measured by ELISA |
| Secondary | Lactulose:rhamnose ratio | 14-18 days | Lactulose:rhamnose ratio of concentration in urine samples collected over 2 hours following oral administration of test dose |
| Secondary | Plasma lipopolysaccharide (LPS) | 14-18 days | Plasma LPS concentration measured by limulus amoebacyte lysate assay |
| Secondary | Plasma biomarker lipopolysaccharide binding protein (LBP) | 14-18 days | Plasma LBP concentration measured by ELISA |
| Secondary | Plasma fatty acid binding protein (FABP) | 14-18 days | Plasma FABP concentration measured by ELISA |
| Secondary | Plasma soluble CD14 | 14-18 days | Plasma concentration of soluble CD14 measured by ELISA |
| Secondary | Plasma CD163 | 14-18 days | Plasma concentration of CD163 measured by ELISA |
| Secondary | Plasma CRP | 14-18 days | Plasma concentration of C-reactive protein measured by ELISA |
| Secondary | Plasma albumin | 14-18 days | Plasma concentration of albumin measured by ELISA |
| Secondary | Mortality | 14 days and 28 days | Number of deaths in each treatment allocation group |
1 to 10 of 21Source ClinicalTrials.gov
See all 21 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03716115
GET https://conductscience.org/api/trials/v1/NCT03716115/registered?page=2